Effect of high shear rate on stability of proteins:: kinetic study

被引:41
作者
Oliva, A [1 ]
Santoveña, A [1 ]
Fariña, J [1 ]
Llabrés, M [1 ]
机构
[1] Univ La Laguna, Fac Farm, Dept Ingn Quim & Tecnol Farmaceut, San Cristobal la Laguna 38200, Spain
关键词
protein stability; size-exclusion chromatography; degradation kinetics; shear rate; validation;
D O I
10.1016/S0731-7085(03)00223-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Size-exclusion chromatography (SEC) was used to monitor the time-course of protein degradation induced by high shear rates during the formulation and manufacture of controlled-release pharmaceutical dosage forms. SEC with multi-angle laser light-scattering (MALLS) detection was used to characterize the aggregation products, determining their absolute molecular weight. A stability-indicating method was developed and validated to obtain reliable drug degradation data. The results obtained according to the ICH guidelines confirm that the system and methods proposed are suitable for their intended use. The degradation kinetics are influenced by the type of protein and the effect of the shear rate on their stability. Reversible pseudo-first order degradation kinetics were observed for bovine beta-lactoglobulin, whereas for human (HSA) and bovine serum albumin (BSA), a monomer-dimer transition was observed, independently of the rate of shear. However, trimer formation was also observed for HSA, especially at high shear rates. The kinetic model may thus be described as a two-step process: a monomer-dimer, and dimer-trimer transition. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 31 条
[1]  
[Anonymous], 1996, INT C HARM ICH TECHN
[2]  
BANGA AK, 1995, THERAPEUTIC PEPTIDES, P131
[3]   PUMP-INDUCED INSULIN AGGREGATION - A PROBLEM WITH THE BIOSTATOR [J].
BRENNAN, JR ;
GEBHART, SSP ;
BLACKARD, WG .
DIABETES, 1985, 34 (04) :353-359
[4]  
BRUMMER P, 2000, PROTEIN FORMULATION, P28
[5]  
Burgess D J, 1992, J Parenter Sci Technol, V46, P150
[6]   TECHNIQUES FOR ASSESSING THE EFFECTS OF PHARMACEUTICAL EXCIPIENTS ON THE AGGREGATION OF PORCINE GROWTH-HORMONE [J].
CHARMAN, SA ;
MASON, KL ;
CHARMAN, WN .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :954-962
[7]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[8]  
GRANT E, 1988, STAT QUALITY CONTROL, P302
[9]  
HORBETT T, 1996, PROTEINS INTERFACES, P1
[10]   A BAYESIAN-ANALYSIS OF THE LINEAR CALIBRATION-PROBLEM [J].
HUNTER, WG ;
LAMBOY, WF .
TECHNOMETRICS, 1981, 23 (04) :323-328